CHA Medical Group

Broker's Calls

Singapore Medial Group a 'buy' as it builds IVF arm

SINGAPORE (Feb 6): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 79 cents.

Broker's Calls

Singapore Medical Group kept at ‘buy’ following price correction

SINGAPORE (April 5): Maybank Kim Eng Research says Singapore Medical Group’s share price correction of close to 8% from its 52-week high presents a “good buying opportunity”.

Broker's Calls

Singapore Medical Group could re-rate following Korean tie-up

SINGAPORE (Feb 20): Singapore Medical Group could see a re-rating as its market recognition and track record grows following its tie-up with Korean healthcare group CHA Medical Group, according to Maybank Kim Eng.

Broker's Calls

Singapore Medical Group set for overseas expansion with new strategic stake partner

SINGAPORE (Feb 17): Singapore Medical Group says a leading Korean healthcare group is taking a 8.8% strategic stake in the provider of premium specialist healthcare services.
×